[New - 7 Covid-19 Realities To Consider In 2023](https://wbbsec.com/opinions-and-features/)
[New - 7 Covid-19 Realities To Consider In 2023](https://wbbsec.com/opinions-and-features/)
powered by bulletin

WHAT WE DO

WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer, a member of the Financial Industry Regulatory Authority, and a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.

Our investment bank has participated in over 250 transactions leading to $4 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from its peers for its equity research and analytics year after year for accuracy and performance by the financial industry’s most highly regarded rankings organizations.

Investment Management

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

Equity Research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

Institutional Sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

Investment Banking

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.

M&A and Strategic Advisory

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.

Equity Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

Press Releases

View All

Opinions & Features

View All

  • In May 2020, Dr. Rick Bright, former director of BARDA, warned Congress that, without ramped up coronavirus pandemic preparedness, we would face the darkest winter in modern history. His warnings were spot on, however there has been precious little follow through and that will be a problem in 2023.

  • I can’t speak to the appropriateness of the prison time. But I believe that no financial award could come close to equivalency for the irreparable harm the Theranos debacle has done to individual patients, the health care system in general, and support for innovation in the field of diagnostics. The damage could not have been greater had they intentionally sought to sabotage health care progress….

  • This winter, the United States is facing the “Perfect Storm” of COVID, flu and Respiratory Syncytial Virus (RSV)…